Balyasny Asset Management LLC Halozyme Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$37.81 - $52.4 $12.7 Million - $17.6 Million	-336,523 Reduced 85.11%	58,897 $3.08 Million
Q1 2024 May 13, 2024	BUY	$33.68 - $41.95 $10.1 Million - $12.5 Million	298,985 Added 310.04%	395,420 $16.1 Million
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $3.92 Million - $4.95 Million	-117,536 Reduced 54.93%	96,435 $3.56 Million
Q3 2023 Nov 14, 2023	SELL	$36.46 - $44.03 $2 Million - $2.42 Million	-54,860 Reduced 20.41%	213,971 $8.17 Million
Q2 2023 Aug 14, 2023	SELL	$30.28 - $38.74 $220,983 - $282,724	-7,298 Reduced 2.64%	268,831 $9.7 Million
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $7.05 Million - $12 Million	214,592 Added 348.72%	276,129 $10.5 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $2.32 Million - $3.44 Million	-57,869 Reduced 48.46%	61,537 $3.5 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $4.6 Million - $6.18 Million	119,406 New	119,406 $4.72 Million
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $226,027 - $290,294	-7,070 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $4.76 Million - $6.09 Million	-149,460 Reduced 95.48%	7,070 $284,000
Q3 2021 Nov 15, 2021	SELL	$38.47 - $46.42 $4.17 Million - $5.03 Million	-108,298 Reduced 40.89%	156,530 $6.37 Million
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $10.3 Million - $13.6 Million	264,828 New	264,828 $12 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $1.25 Million - $1.63 Million	-31,643 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $816,705 - $1.38 Million	31,643 New	31,643 $1.35 Million
Q2 2018 Aug 14, 2018	SELL	$16.87 - $20.3 $674,884 - $812,101	-40,005 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $682,485 - $848,106	40,005 New	40,005 $784,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$831 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$608 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$313 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$192 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$161 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account